Skip to main content
. 2014 Dec 1;14(2):277–288. doi: 10.1074/mcp.M114.041632

Table I. Description of the sample cohort.

Stagea TNMb Agec Sex Tumor size(cm) Tumor histologyd
Adenoma 84 F Large Severe dysplasia
Adenoma 79 F Large Severe dysplasia
Adenoma 72 F 2 Severe dysplasia
Adenoma 64 M 10 Severe dysplasia
Adenoma 52 M 2 Severe dysplasia
A T2N0M0 49 F 4 Adeno, G1
A T2N0M0 59 M 3 Adeno, G2
A T2N0M0 59 M 14 Adeno, G2
A T2N0M0 53 M 2 Adeno, G2
B T3N0M0 87 M 5 Adeno, G2
B T3N0M0 71 M 7 Adeno, G2
B T3N0M0 76 F 7 Adeno, G2
B T3N0M0 56 M 5 Adeno, G2
C T3N1M0 74 M 3 Adeno, G2
C T3N1M0 61 M 4 Adeno, G2
C T3N1M0 55 F 5 Adeno, G2
C T3N2M0 84 M 4 Adeno, G2
D T3N1M1 56 F 7 Adeno, G2
D T3N2M1 82 M 5 Adeno, G2
D T3N2M1 66 M 5 Adeno, G3
D T4N2M1 28 M 6 Adeno, G3
D T3N1M1 50 M 5 Adeno, G3
D T3N2M1 64 F 3 Adeno, G3

a Dukes A-D,

b TNM, tumor node metastasis,

c Age at diagnosis,

d Dysp.gravis = Dysplasia gravis, Adeno = Adenocarcinoma, G = Grade(1–4, WHO).